FDA Adverse Event Injury Summary report: N

AXIOM IMPLANT 3.4 X 8.0

MDR report key: 11985412 · Received June 11, 2021

Report

Report Number
0008020776-2021-02429
Event Type
Injury
Date Received
June 11, 2021
Date of Event
May 8, 2021
Report Date
June 11, 2021
Manufacturer
ANTHOGYR
Product Code
DZE
UDI-DI
03663394000055
PMA / PMN Number
K101913
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
DENTIST

Narratives

Additional Manufacturer Narrative · 1

THE BATCH NUMBER COULD BE VERIFIED. OUR MANUFACTURING Q-SYSTEM ASSURES, THAT PRODUCTION AND PROCESS CONTROLS ARE IN PLACE TO ENSURE THAT BATCHES CONFIRM TO THE APPLICABLE SPECIFICATIONS BEFORE THEY ARE DISTRIBUTED.  THE LOSS OF AN ENDOSSEOUS DENTAL IMPLANT AFTER SUCCESSFUL OSSEOINTEGRATION AND RESTORATION IS A KNOWN INHERENT RISK OF THE PROCEDURE. IMPLANTS MAY HAVE TO BE REMOVED IN CASE ONE OR MORE OF THE IMPLANT SUCCESS CRITERIA ARE NOT MET. IMPLANT SUCCESS CRITERIA ACCORDING TO BUSER ET AL. (1991) ARE: ABSENCE OF PERSISTENT SUBJECTIVE COMPLAINTS SUCH AS PAIN, FOREIGN BODY SENSATION AND /OR DYSESTHESIA. ABSENCE OF A RECURRENT PERI-IMPLANT INFECTION WITH SUPPURATION. ABSENCE OF IMPLANT MOBILITY. ABSENCE OF A CONTINUOUS RADIOLUCENCY AROUND THE IMPLANT. THE MANUFACTURER'S TREND ANALYSIS CONFIRMS THAT THE REPORTED FAILURE RATE ASSOCIATED WITH ITS DENTAL IMPLANTS IS BELOW THE EXPECTED FAILURE RATE FOR THIS TREATMENT AS PUBLISHED IN THE SCIENTIFIC LITERATURE.

Description of Event or Problem · 1

THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2017 IN FDI 45. ON (B)(6) 2021 , LOSS OF OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. THERE WERE NO PATIENT OPERATIVE OR POST-OPERATIVE COMPLICATIONS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
883919 AXIOM IMPLANT 3.4 X 8.0 ENDOSSEOUS DENTAL IMPLANT DZE ANTHOGYR OP34080 16-137735 03663394000055

Patients

Seq Age Sex Outcome Treatment
1 61 YR Required Intervention